Rutgers University
New Brunswick, New Jersey, 08901, United States
Location contact
Andrea C Villanti, PhD, MPH
PRINCIPAL_INVESTIGATOR
Kymberle L Sterling, DrPH
PRINCIPAL_INVESTIGATOR
Study Coordinator
CONTACT
NCT Number: NCT07543081
Our study tests a multi-level anti- disinformation message (ADM) campaign on menthol cigarette and flavored cigar policies in Black adults.
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Not applicable
New Brunswick, New Jersey, 08901, United States
Andrea C Villanti, PhD, MPH
PRINCIPAL_INVESTIGATOR
Kymberle L Sterling, DrPH
PRINCIPAL_INVESTIGATOR
Study Coordinator
CONTACT
This study uses a prospective, randomized factorial trial design to evaluate delivery of anti-disinformation messaging (ADM) on Black adults' receptivity to flavored tobacco policies, beliefs about the tobacco industry, and beliefs about menthol cigarettes and flavored cigars. Eligible, consenting participants will complete the baseline survey, providing sociodemographic information and baseline measures of study outcomes. Participants will then be randomized, stratified by study site (Atlanta, GA or Birmingham, AL), in a 1:1 ratio within the survey platform to either the individually-delivered ADM intervention or control condition. Participants in the intervention condition (Intervention-I) will receive their first exposure to the ADM intervention at the end of baseline survey. At follow-up assessments (3-months, 6-months, 9-months, 12-months), all participants will complete study measures and at 3-, 6-, and 9-month follow-up assessments, Intervention-I participants will be exposed to the ADM intervention at the end of the survey. Six months after our first enrollment in the trial, Atlanta will receive the community-delivered ADM intervention, while Birmingham serves as the control community. Community partners in Atlanta, our Intervention Community (Intervention-C), will disseminate our ADM intervention messages through their community networks for 12 months, overlapping at least six months with the delivery of the individual-level intervention (Intervention-I) in our enrolled participants. Upon completion of the final assessment (12-month follow-up), all participants will be exposed to the ADM intervention within the survey platform and asked to complete measures on perceived message effectiveness and credibility of the study messages.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-
Participants in this condition will be exposed to anti-disinformation messages (ADM) designed to increase correct beliefs about menthol cigarettes, flavored cigars, the purpose, and limits of flavored tobacco policies. The delayed intervention control condition in this study will receive the ADM intervention after outcome measures are collected at the last assessment.
Our community-level campaign will distribute our ADM messages to our Intervention Community via social media, print ads and posters, radio ads, and community events. These messages will be delivered over 1 year, with monthly delivery activities led by EAB members in the Intervention Community.
Time frame: 3, 6, 9, 12 months
Beliefs items address tobacco industry behaviors, including funding Black community organizations, paying Black lobbyists to oppose public health policies, and targeting Black and African American communities with menthol cigarette and flavored cigar marketing.
Time frame: 3, 6, 9, 12 months
Items address prevalence of menthol cigarette and flavored cigar use in Black and African Americans and role of menthol/flavors in tobacco initiation, progression, and cessation.
Time frame: 3, 6, 9, 12 months
Items address the public health purpose and limits of flavored tobacco policies.
Time frame: 3, 6, 9, 12 months
Items address plans to support local, state, and federal policies regarding flavored tobacco products.
Contact information is provided by the study sponsor or research team.
Rutgers, The State University of New Jersey
Other
The Unvarnished Truth: Pursuing Health Equity by Correcting Disinformation Targeting African Americans About the FDA's Proposed Ban on Menthol Cigarettes and Flavored Cigars
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07551531
Behavior, Kidney Transplant
Livingston, New Jersey, United States
View Trial DetailsNCT07735832
Behavior, Behavioral Symptoms
Madrid, Spain
View Trial DetailsNCT07733531
Behavior, Combat Disorders
Austin, Texas, United States
View Trial DetailsNCT07728370
Behavior, Cervical Cancer Stigma
Houston, Texas, United States
View Trial Details